Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Nuvo Research reorganizes as Nuvo Pharmaceuticals, divests pipeline assets into newco Crescita

Executive Summary

Finalizing a divestiture first announced in Q4 2015, Nuvo Research Inc. has now reorganized into two TSX-traded companies, spinning off its topical delivery technologies and pipeline candidates into a separate entity named Crescita Therapeutics Inc., which is focused on drug development. Operating on its own, Nuvo Research keeps its current TSX listing, but changed the company name to Nuvo Pharmaceuticals Inc., which retains Nuvo Research's existing commercial assets and pharmaceutical manufacturing capabilities.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Topical Delivery
      • Transdermal
Deal Status
  • Final
Deal Type
  • Acquisition
    • Divestiture/Spin-Out

Related Companies